养血生发胶囊相关肝损害风险分析  

Hepatic Lesion Risk Analysis of Yangxueshengfa Capsule

作　　者：杨乐[1] 郭晓昕[1] 宋海波[1] 

机构地区：[1]国家食品药品监督管理局药品评价中心,北京100045

出　　处：《中国药物警戒》2013年第6期362-365,共4页Chinese Journal of Pharmacovigilance

摘　　要：通过对养血生发胶囊安全性相关的国内文献报道、上市后的安全性研究状况进行分析,评价养血生发胶囊上市后的安全性情况(肝损害)及风险特点,提出符合药品本身特点的风险控制措施,为安全、合理使用该药提供建议。By reviewing the relevant references and reports of the adverse drug reaction cases of Yangxueshengfa capsule in China, the post-marketing safety and risks（hepatic lesion） in post-marketing period of Yangxueshengfa capsule were reevaluated in this article, t/Ask management measures according to the characteristics of medicine were put forward. Suggestions were proposed for a safe and rational use of this medicine.

关 键 词：养血生发胶囊 风险分析 措施 

分 类 号：R282[医药卫生—中药学]